The 2025 ISPE Europe Annual Conference will take place 12 – 14 May in London, United Kingdom (UK), and virtually.
NORTH BETHESDA, Md., April 2, 2025 /PRNewswire/ -- The International Society for Pharmaceutical Engineering () has announced its keynote speakers and plans to debut new workshops at the , taking place Monday, 12 May, through Wednesday, 14 May, in London, UK, and virtually.
The conference agenda is meticulously crafted to reflect current dynamics in the pharmaceutical landscape, with useful case studies around navigating regulatory expectations, implementing Pharma 4.0â„¢, and exploring emerging technologies such as AI and machine learning, virtual and augmented reality, and smart manufacturing. Attendees will also learn about topics that are relevant to their day-to-day work, from assessing risks to designing test approaches and setting baseline metrics.
The 2025 ISPE Europe Annual Conference has a strong regulatory presence with European health authorities attending and presenting. "I look forward to participating in the 2025 ISPE Europe Annual Conference," said Evdokia Korakianiti, Head of Quality and Safety of Medicines, European Medicines Agency (EMA). "I plan to present on the role of regulators as enablers for innovation to facilitate the development of new therapies and enhance the supply of existing medicines to patients."
Confirmed featured speakers include:
- Kevin Bailey, GMP Inspector, the Medicines and Healthcare products Regulatory Agency (MHRA)
- Vanessa Bennett, Senior Medicines and Medical Device Shortage Specialist, European Medicines Agency (EMA)
- Brendan Cuddy, Lead Scientific Officer, EMA
- Ian Jackson, Expert GMP Inspector, MHRA
- Evdokia Korakianiti, Head of Quality and Safety of Medicines, EMA
- Rasmus Pedersen, Associate Director, KojoX and Technology Development, FUJIFILM Diosynth Biotechnologies
- James Pound, Deputy Director Standards and Compliance, MHRA
- Ilaria Lo Presti, Senior Manager of PSC Global Engineering, GSK
- Kirsty Reid, Director, Science Policy, European Federation of Pharmaceutical Industries and Associations
"Attendees will have the chance to hear from industry leaders and regulators who will share their perspectives on some of the most important topics the pharmaceutical industry is facing: sustainability and drug shortages, digital transformation, GAMP®, biotechnology in large molecules, cell and gene therapy, advanced therapeutical medicinal products (ATMPs), good engineering practice, and investment management," said Heather Watson, Conference Chair for the 2025 ISPE Europe Annual Conference and Director of TenTenTen Consulting Limited. "They can also participate in workshops, which are being included as part of the conference program for the first time this year."
The new workshops will cover the following topics:
- "Drug Shortages"
- "Digital Transformation and GAMP"
- "Substances of Concern and Sustainability"
- "Critical Success Factors for Digital Transformation Excellence"
Learn more and register for the 2025 ISPE Europe Annual Conference today by visiting .
About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 22,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit .
Media Contact
Katie LeChase, ISPE, +1-360-718-9771, [email protected],
SOURCE ISPE
Share this article